BiomX (PHGE) EPS (Basic) Growth (1y) (2019 - 2026)
BiomX (PHGE) EPS (Basic) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 322.67% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 96.41% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -16.29% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -147.33% |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | 17.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.22% |
| Dec 31, 2025 | 133.92% |
| Sep 30, 2025 | 194.29% |
| Jun 30, 2025 | 240.95% |
| Dec 31, 2024 | 80.91% |
| Sep 30, 2024 | -123.73% |
| Jun 30, 2024 | -111.00% |
| Dec 31, 2023 | -277.21% |
| Sep 30, 2023 | 157.56% |
| Jun 30, 2023 | 149.49% |
| Mar 31, 2023 | 27.88% |
| Dec 31, 2022 | 228.09% |
| Sep 30, 2022 | 38.81% |
| Jun 30, 2022 | 16.69% |
| Mar 31, 2022 | 21.76% |
| Dec 31, 2021 | -0.61% |
| Sep 30, 2021 | -197.07% |
| Jun 30, 2021 | -211.64% |
| Mar 31, 2021 | -236.16% |
| Sep 30, 2020 | -94.25% |